SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo

Open Access

Peer-reviewed

Research Article

Anna Bobrowska,

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
⨯
Gizem Donmez,

Current address: Department of Neuroscience, Tufts University School of Medicine, Boston, Massachusetts, United States of America

Affiliation Paul F. Glenn Laboratory and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯
Andreas Weiss,

Affiliation Neuroscience Discovery, Novartis Institutes for BioMedical Research, Basel, Switzerland
⨯
Leonard Guarente,

Affiliation Paul F. Glenn Laboratory and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America
⨯
Gillian Bates

* E-mail: gillian.bates@kcl.ac.uk

Affiliation Department of Medical and Molecular Genetics, King's College London, London, United Kingdom
⨯

Reader Comments (0)

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Huntington disease
Is the Subject Area "Huntington disease" applicable to this article?

Thanks for your feedback.
Tubulins
Is the Subject Area "Tubulins" applicable to this article?

Thanks for your feedback.
Biosynthesis
Is the Subject Area "Biosynthesis" applicable to this article?

Thanks for your feedback.
Brainstem
Is the Subject Area "Brainstem" applicable to this article?

Thanks for your feedback.
Acetylation
Is the Subject Area "Acetylation" applicable to this article?

Thanks for your feedback.
Genetics of disease
Is the Subject Area "Genetics of disease" applicable to this article?

Thanks for your feedback.